In this study, we
successfully synthesized boranophosphate (PB),
phosphorothioate (PS), and phosphate (PO) chimeric oligonucleotides
(ODNs) as a candidate for the antisense oligonucleotides (ASOs). The
PB/PS/PO-ODNs were synthesized utilizing
H
-boranophosphonate,
H
-phosphonothioate, and
H
-phosphonate monomers.
Each monomer was condensed with a hydroxy group to create
H
-boranophosphonate,
H
-phosphonothioate,
and
H
-phosphonate diester linkages, which were oxidized
into PB, PS, and PO linkages in the final stage of the synthesis,
respectively. As for condensation of an
H
-phosphonothioate
monomer, regulating chemoselectivity was necessary since the monomer
has two nucleophilic centers: S and O atoms. To deal with this problem,
we used phosphonium-type condensing reagents, which could control
the chemoselectivity. In this strategy, we could synthesize PB/PS/PO
oligomers, including a 2′-OMe gapmer-type dodecamer. The physiological
and biological properties of the synthesized chimeric ODNs were also
evaluated. Insights from the evaluation of physiological and biological
properties suggested that the introduction of suitable
P
-modification and sugar modification at proper sites of ODNs would
control the duplex stability, nuclease resistance, RNase H-inducing
ability, and one base mismatch discrimination ability, which are critical
properties as potent ASOs.